BetterLife Pharma Inc. Announces Pricing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
pharmaceutical investing BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
pharmaceutical investing BetterLife's Non-hallucinogenic LSD For Treating Mood Disorders Highlighted in Drug Discovery & Development Article
pharmaceutical investing Promise of BetterLife's Non-hallucinogenic LSD For Treating Mood Disorders Highlighted in Medical Xpress Article
pharmaceutical investing BetterLife Files Amended and Restated Offering Document for Offering of Units
pharmaceutical investing Omineca Announces Upsized and Fully Allocated $2.8 Million Brokered Financing of Flow-Through Units
pharmaceutical investing Betterlife Publishes Promising Results from a Study Titled "A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders"
Brixton Metals Drills 6,199 g/t Silver over 1.00 m including 0.50 m of 12,386 g/t Silver in Hole 432 at its Langis Project in Ontario
SAGA Metals Commences Diamond Drilling at the Wolverine Heavy Rare Earth Element Project in Labrador - First Two Diamond Drill Holes Intersected Prospective REE-Bearing Volcanic Unit
